Gules, O. Et Al. 2023. Cytotoxic activity of TRPV4 antagonist RN-1734 in G-361 human melanoma cancer cell line. Cukurova Medical Journal , vol.48, no.3 , 939-947.

Gules, O., Bilici, E., Kurbasevic, E., Lenger, Ö. F., Boyacioglu, M., & Epikmen, E. T., (2023). Cytotoxic activity of TRPV4 antagonist RN-1734 in G-361 human melanoma cancer cell line. Cukurova Medical Journal , vol.48, no.3, 939-947.

Gules, Ozay Et Al. "Cytotoxic activity of TRPV4 antagonist RN-1734 in G-361 human melanoma cancer cell line," Cukurova Medical Journal , vol.48, no.3, 939-947, 2023

Gules, Ozay Et Al. "Cytotoxic activity of TRPV4 antagonist RN-1734 in G-361 human melanoma cancer cell line." Cukurova Medical Journal , vol.48, no.3, pp.939-947, 2023

Gules, O. Et Al. (2023) . "Cytotoxic activity of TRPV4 antagonist RN-1734 in G-361 human melanoma cancer cell line." Cukurova Medical Journal , vol.48, no.3, pp.939-947.

@article{article, author={Ozay Gules Et Al. }, title={Cytotoxic activity of TRPV4 antagonist RN-1734 in G-361 human melanoma cancer cell line}, journal={Cukurova Medical Journal}, year=2023, pages={939-947} }